PetMed Express, Inc. (NASDAQ:PETS) Director Robert C. Schweitzer sold 5,000 shares of the stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $48.60, for a total value of $243,000.00. Following the completion of the sale, the director now owns 83,834 shares of the company’s stock, valued at approximately $4,074,332.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of PetMed Express, Inc. (PETS) opened at 44.29 on Friday. PetMed Express, Inc. has a 12 month low of $18.90 and a 12 month high of $50.90. The stock has a 50 day moving average price of $44.40 and a 200 day moving average price of $31.08. The firm has a market capitalization of $898.73 million, a P/E ratio of 34.07 and a beta of 0.99.
PetMed Express (NASDAQ:PETS) last posted its quarterly earnings results on Monday, July 24th. The company reported $0.45 EPS for the quarter, beating the Zacks’ consensus estimate of $0.38 by $0.07. PetMed Express had a net margin of 10.34% and a return on equity of 28.67%. The company had revenue of $79.66 million during the quarter, compared to analyst estimates of $77.32 million. During the same period in the prior year, the business posted $0.32 EPS. The firm’s revenue was up 9.9% compared to the same quarter last year. On average, analysts expect that PetMed Express, Inc. will post $1.44 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, August 18th. Investors of record on Monday, August 7th were issued a dividend of $0.20 per share. The ex-dividend date was Thursday, August 3rd. This represents a $0.80 dividend on an annualized basis and a yield of 1.81%. PetMed Express’s dividend payout ratio is currently 61.54%.
ILLEGAL ACTIVITY WARNING: This report was first reported by BNB Daily and is the sole property of of BNB Daily. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.baseball-news-blog.com/2017/08/19/petmed-express-inc-pets-director-robert-c-schweitzer-sells-5000-shares-updated-updated.html.
A number of analysts have recently issued reports on the company. Noble Financial restated a “hold” rating on shares of PetMed Express in a report on Wednesday, July 26th. Northcoast Research upgraded PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price objective for the company in a report on Monday, July 24th. Zacks Investment Research upgraded PetMed Express from a “hold” rating to a “strong-buy” rating and set a $38.00 price objective for the company in a report on Wednesday, May 10th. Finally, Craig Hallum lowered PetMed Express from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th.
A number of large investors have recently bought and sold shares of the stock. Acrospire Investment Management LLC bought a new position in shares of PetMed Express during the second quarter valued at approximately $110,000. Pinebridge Investments L.P. raised its position in shares of PetMed Express by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 2,704 shares of the company’s stock valued at $110,000 after buying an additional 27 shares during the period. Westside Investment Management Inc. raised its position in shares of PetMed Express by 15.8% in the first quarter. Westside Investment Management Inc. now owns 5,502 shares of the company’s stock valued at $114,000 after buying an additional 752 shares during the period. Fred Alger Management Inc. bought a new position in shares of PetMed Express during the second quarter valued at approximately $162,000. Finally, State of Alaska Department of Revenue raised its position in shares of PetMed Express by 76.7% in the second quarter. State of Alaska Department of Revenue now owns 4,028 shares of the company’s stock valued at $163,000 after buying an additional 1,748 shares during the period. Institutional investors own 79.12% of the company’s stock.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.